Ravi Shankar Jandhyala

Ravi Shankar Jandhyala

Director DIN 07547067
DIN 07547067 First appointment Jul 2016
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 3 historical roles
Total affiliations 3 Since Jul 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Shankar Jandhyala

Data last updated:

Ravi Shankar Jandhyala was a Director at Rsn Pharma Private Limited (from 2016), Director at Rsn Mega Projects Private Limited (from 2016) and Director at Rsn Life Sciences Private Limited (from 2016).

DIN 07547067
First Appointment 26 Jul 2016
Oldest Company Age 10 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rsn Pharma Private Limited U33100TG2016PTC111167
Director28 Jul 20162016Strike Off
Rsn Mega Projects Private Limited U45500TG2016PTC111147
Director27 Jul 20162016Strike Off
Rsn Life Sciences Private Limited U33113TG2016PTC111126
Director26 Jul 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rsn Pharma Private Limited
Rsn Mega Projects Private Limited
Rsn Life Sciences Private Limited
Premium access

Shareholding and investment profile for Ravi Shankar Jandhyala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Shankar Jandhyala

Ravi Shankar Jandhyala was first appointed on 26 Jul 2016 as Director at Rsn Life Sciences Private Limited.

Ravi Shankar Jandhyala held 3 earlier board appointments: Rsn Pharma Private Limited (Director, from 28 Jul 2016); Rsn Mega Projects Private Limited (Director, from 27 Jul 2016); Rsn Life Sciences Private Limited (Director, from 26 Jul 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available